论文部分内容阅读
目的 :探索神经生长因子穴位注射集合功能训练方法治疗脑卒中上肢功能障碍疗效。方法 :选取2015年12月—2016年12月在我院康复中心进行治疗的脑卒中后上肢功能障碍患者150例作为研究对象,根据入院时间不同采用随机数字法将其平均分为对照组和观察组,其中对照组(75例)采用常规康复训练治疗,观察组(75例)在常规康复训练治疗基础上进行穴位注射神经生长因子治疗,利用FMA、MBI和IEMG三项评分分别对患者治疗前后的上肢运动障碍、生活自理能力和神经肌肉系统功能进行比较分析。结果 :两组脑卒中患者的上肢功能恢复情况治疗后的FMA和MBI评分显著优于治疗前,存在着统计学差异(P<0.05);观察组治疗后的FMA、MBI显著的优于对照组,存在显著的统计学差异(P<0.05);两组治疗后的肱三头肌和肱二头肌的IEGM评分显著的优于治疗前,存在统计学差异(P<0.05);观察组中治疗后的肱三头肌和肱二头肌的IEGM评分显著的优于对照组,存在统计学差异(P<0.05)。结论 :穴位注射神经生长因子集合功能训练治疗能够加快脑卒中患者上肢功能障碍的恢复速度,改善脑卒中患者预后,提高患者的生活质量,该治疗方法值得在临床进行推广。
Objective: To explore the curative effect of NGF injection training on stroke patients with upper extremity dysfunction. Methods: From December 2015 to December 2016 in our hospital rehabilitation center for the treatment of 150 patients with upper extremity dysfunction after stroke as a research object, according to different admission time using random number method were divided equally into the control group and observation The control group (75 cases) was treated by routine rehabilitation training. The observation group (75 cases) received the acupoint injection of nerve growth factor (NGF) on the basis of routine rehabilitation training. The three scores of FMA, MBI and IEMG Of the upper limb movement disorders, self-care ability and neuromuscular system function comparative analysis. Results: The scores of FMA and MBI after stroke in both groups were significantly better than those before treatment (P <0.05). The FMA and MBI in the observation group were significantly better than those in the control group (P <0.05). The IEGM scores of triceps and biceps after treatment were significantly better than those before treatment (P <0.05). In the observation group The IEGM scores of triceps and biceps after treatment were significantly better than those of the control group, with statistical difference (P <0.05). Conclusion: Acupoint injection of nerve growth factor (NGF) training can accelerate the recovery of upper limb dysfunction in stroke patients, improve the prognosis of patients with stroke, and improve the quality of life of patients. This treatment is worthy of clinical promotion.